NGL Fine-Chem Ltd

NGLFINE

Company Profile

  • Business description

    NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.

  • Contact

    301, E Square, Subhash Road
    Vile Parle (East)
    MumbaiMH400057
    IND

    T: +91 2240842222

    https://www.nglfinechem.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2026

    Employees

    523

Stocks News & Analysis

stocks

Are we as bullish on Oracle as the market?

Shares jumped in response to the latest results.
stocks

Anglo American strikes deal to create a new copper giant

We are surprised that Teck agreed to the merger on these terms, and wouldn’t be surprised if there is a twist in the tale.
stocks

The ‘other’ AI chip behemoth that might just be getting started

The magnitude of growth at Broadcom continues to astound us.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,071.409.10-0.10%
CAC 407,835.3173.990.95%
DAX 4023,744.73111.780.47%
Dow JONES (US)45,935.55444.630.98%
FTSE 1009,284.0858.690.64%
HKSE26,086.32113.94-0.43%
NASDAQ21,984.5798.510.45%
Nikkei 22544,372.50534.831.22%
NZX 50 Index13,229.1547.09-0.35%
S&P 5006,568.0936.050.55%
S&P/ASX 2008,805.008.80-0.10%
SSE Composite Index3,875.3163.091.65%

Market Movers